Bank Pictet & Cie (Europe)’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
CS
Bank Pictet & Cie (Europe)'s GH Position: Q4 2022 in Review
Bank Pictet & Cie (Europe) sold out of Guardant Health (GH) in Q4 2022, closing a stake of 6,784 shares — an estimated $365K sold.
Bank Pictet & Cie (Europe) first reported a position in GH in Q1 2021 and held it in 7 quarters. The position peaked at $996K in Q3 2021. 292 funds tracked by Wall St. Rank hold GH as of Q4 2022.
- Bank Pictet & Cie (Europe) reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
- Bank Pictet & Cie (Europe) sold 6,784 Guardant Health shares in Q4 2022, an estimated $365K.
- Bank Pictet & Cie (Europe) first reported a position in Guardant Health in Q1 2021 and held it in 7 quarters.
- Bank Pictet & Cie (Europe)'s Guardant Health position peaked at $996K in Q3 2021.
- 292 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2022, filed 8 Feb 2023.